Would you consider selling your company?
We develop your company through active ownership through a successful process for integration and growth.
Do you have a profitable life science company in a leading niche position with opportunities to grow or are you facing a generational shift but want your company to keep the identity?
AddLife offers an attractive option with a decentralized business model. The subsidiaries continue to run their business with current management and under their own brand. AddLife adds financial stability, skills and tools that make it easier and more efficient to grow the business. For example, we have AddLife Academy and knowledge-sharing networks.
Contact us and let's see what opportunities we have together.
Extensive experience of acquisitions
Acquisitions is a vital part of AddLife´s growth strategy and over the years, AddLife has acquired more than 30 companies. From this experience, a clear and structured process has been developed for the successful integration and development of acquired companies.
A successful acquisition can take several years, which improves the prospects of a satisfactory result for both parties.
What are we looking for?
- European life science companies
- Strong position in a market niche
- Profitable and well-managed companies
- Corporate philosophy and culture in line with AddLife
- Sustainable business model
- Continued commitment from management and key employees
What are we offering?
- Financial stability
- Collaboration and knowledge sharing with other AddLife companies
- AddLife Academy offers trainings in e.g. sales and leadership
- Decentralised business model where the company keeps its brand, identity and culture
- Competence and resources within sustainability, digitalisation and business development
Smooth and efficient acquisition process
- Kenneth Söderhäll, MD JK Lab Nordic
Discussions about an extended collaboration with BergmanLabora began in the fall of 2018. Since then, there have been many cups of coffee and an exchange of thoughts and ideas. Once we agreed that it would be a good idea for the companies to merge, it was presented to AddLife. After that, it went quickly, from presented business idea to completed acquisition in less than six months.
|Acquisitions||Country||Time||Net Sales, SEKm||No of employees||Business Area|
|JK Lab Nordic||Sweden||July, 2022||24||6||Labtech|
|BioCat GmbH||Germany||April, 2022||90||20||Labtech|
|O’Flynn Medical Ltd||Ireland||April, 2022||64||36||Medtech|
|MBA Incorporado S.L||Spain||January, 2022||670||285||Medtech|
|Telia Health Monitoring||Sweden||March, 2022||4||8||Medtech|
|Camanio AB||Sweden||December, 2021||13||18||Medtech|
|Fischer Medical ApS||Denmark||November, 2021||60||12||Medtech|
|Bio-Connect Group||Benelux||September, 2021||140||31||Labtech|
|Healthcare 21 Group||Irland, UK||April, 2021||1 700||450||Medtech|
|Vision Ophthalmology Group||Switzerland, Germany, the UK, Poland||April, 2021||700||190||Medtech|
|Biomedica Italia s.r.l.||Italy||December, 2020||80||17||Medtech|
|Zafe Care Systems AB||Sweden||October, 2020||34||21||Medtech|
|DACH Medical Group||Austria, Switzerland and Germany||October, 2020||140||23||Medtech|
|Ropox A/S||Denmark||October, 2020||91||73||Medtech|
|Technipro-Pulmomed Pty Limited||Australia||August, 2020||12||5||Medtech|
|Euroclone S.p.A.||Italy||January, 2020||280||58||Labtech|
|Funksjonsutstyr AS||Norway||December, 2019||50||6||Medtech|
|Fysionord i Sollefteå||Sweden||September, 2019||6||2||Medtech|
|Lab-Vent Controls A/S and Koldt & Ryø El A/S||Denmark||August, 2019||52||20||Labtech|
|Business from Wellspect HealthCare||Sweden||April, 2019||170||14||Medtech|
|Biomedica Medizinprodukte GmbH||Austria||December, 2018||650||280||Labtech|
|Laboren ApS||Denmark||December, 2018||10||2||Labtech|
|Väinö Korpinen Oy||Finland||July, 2018||80||15||Medtech|
|Food Diagnostics AB||Sweden||March, 2018||10||3||Labtech|
|Ossano Scandinavia AB||Sweden||February, 2018||22||5||Medtech|
|Krabat AS||Norge||July, 2017||30||13||Medtech|
|Hepro AS||Norge||March, 2017||165||40||Medtech|
|TM Techno Medica AB||Sweden||January, 2017||30||5||Medtech|
|Biolin Scientific AB||Sweden||December, 2016||100||68||Labtech|
|Svan Care AB||Sweden||October, 2016||35||13||Medtech|
|V-Tech AB and Esthe-Tech AB||Sweden||April, 2016||50||11||Medtech|
Commitment to our customers' success
Martin Angehrn, Vice President AddVision
For us, it is important that our customers succeed and that the patient gets what she needs. This commitment to help our customers and patients is visible in our employees action. If a surgeon lacks the correct intraocular lens for the next days operation, we make sure to deliver it in time, even if that means bringing it ourselves. In this way, we help improve people's lives so the surgeon can do her job and the patient receives the best possible care.
Business Area Manager Medtech
Business Area Manager Labtech